Pharmacological Evaluation of Aldehydic-Pyrrolidinedione Against HCT-116, MDA-MB231, NIH/3T3, MCF-7 Cancer Cell Lines, Antioxidant and Enzyme Inhibition Studies

Pharmacological Evaluation of Aldehydic-Pyrrolidinedione Against HCT-116, MDA-MB231, NIH/3T3, MCF-7 Cancer Cell Lines, Antioxidant and Enzyme Inhibition Studies

Ashfaq Ahmad,1 Farhat Ullah,1 Abdul Sadiq,1 Muhammad Ayaz,1 Haroon Rahim,2 Umer Rashid,3 Sajjad Ahmad,1 Muhammad Saeed Jan,1 Riaz Ullah,4 Abdelaat A Shahat,4,5 Hafiz Majid Mahmood6 1Department of Pharmacy, University of Malakand, Chakdara, Dir (L), KP (Khyber Pakhtunkhwa) 18000, Pakistan; 2Departmen...

Full description

Bibliographic Details
Main Authors: Ahmad A, Ullah F, Sadiq A, Ayaz M, Rahim H, Rashid U, Ahmad S, Jan MS, Ullah R, Shahat AA, Mahmood HM
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:Drug Design, Development and Therapy
Subjects:
succinimide
alzheimer's disease
mtt
oxidative stress
diabetes
helminthiasis
Online Access:https://www.dovepress.com/pharmacological-evaluation-of-aldehydic-pyrrolidinedione-against-hct-1-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/pharmacological-evaluation-of-aldehydic-pyrrolidinedione-against-hct-1-peer-reviewed-article-DDDT

Similar Items